Facial Injectables Market By Product Type (Dermal Fillers, Botox), By End-user (Hospitals, Dermatology Centers, Physicians Office), By Region (North America, Europe, Asia Pacific, RoW) – Global Forecast up to 2025

Global Facial Injectables Market by Product Types (Dermal Fillers, Botox), By End-users (Hospitals, Dermatology Centers, Physicians Office), and By Regions (North America, Europe, Asia Pacific, and Rest of the World) Global Forecast up to 2025

This market research report includes a detailed segmentation of the global facial injectables market by product types (dermal fillers and Botox), by end-users (hospitals, dermatology centers, and physicians office), and by regions (North America, Europe, APAC, and RoW).

Research Overview

It predicts that the global facial injectables market will grow at a CAGR of 10.81% during the forecast period 20192025. Facial injectables refer to the aesthetic treatment of the skin that results in a more youthful look. There are a variety of aesthetic procedures performed, including those used to treat skin conditions (deep lines & wrinkles), change the contours of jaw or lips, scars & depressions in the skin resulting from acne, congenital or injury imperfections, etc. Dermal fillers and Botox are the top-leading products used to treat these skin conditions. Dermal fillers offer treatment to face, neck, and hands, thereby resulting in a smooth, fuller, and more youthful look. Dermal fillers are increasingly being adopted due to immediate positive results, which have become popular globally. There are temporary fillers that are absorbed by the body and are classified into collagen-based fillers, hyaluronic acid-based fillers, calcium hydroxylapatite, and poly-L-lactic acid. These have provisional results and are used every 46 months. Permanent fillers are made of polymethylmethacrylate (PMMA), which are not absorbed by the body. ArteFill is among the most common brand used as permanent fillers.
An increase in beauty consciousness, growing awareness about facial injections, increasing demand for non-surgical & minimally invasive cosmetic surgeries, and anticipated launch of new products are expected to drive the market growth during the forecast period. The market is also witnessing few emerging trends, including increase in demand for combination treatments, rise in medical tourism, and increasing disposable income, which will drive the market at a significant pace during the forecast period. The facial injectables market in Brazil, India, China, and Russia is also expected to grow at a rapid pace during the forecast period as the adoption of cosmetic procedures in these countries is high.

Most of the vendors are focusing on evidence-based clinical results for the development and advancement of the product. The advancements in technology, the emergence of innovative products with the adoption of minimally invasive procedures, and the demand for facial injectables for the treatment of various skin conditions are driving the market growth.

The market is fueled by innovation and new technological techniques & procedures. The presence of large, small, and local vendors in the market has led to high competition among them. The global facial injectables market is dominated by Allergan, Galderma, Merz Pharma, and Ipsen. These vendors are consistently increasing their footprint in the market; regional vendors are finding it more difficult to compete with larger players, especially on quality, pricing, market reach, and financial resources. Further, they are expanding their inorganic growth by acquiring regional or local players.

Segmentation by Product Types:
Dermal Fillers
Botox

The market players compete on various factors: price, availability, brand, and variety. Price is set to become a major base for competition among players specializing in certain products to gain an edge in the market. The companies with better-skilled workforce and financial resources are able to manufacture products that may render competitors merchandise non-competitive even before they are launched. This makes it difficult for the latter to recover R&D and commercialization costs. As a result, vendors must develop new products and stay abreast of emerging market trends that influence their product lines.

Segmentation by End-users:
Hospitals
Dermatology Centers
Physicians Office

In 2018, dermatology centers gained the highest share in the facial injectables market with a large volume of cosmetic treatments globally.
Segmentation by Regions:
North America
Europe
Asia Pacific
RoW

According to the analysis, North America accounted for the largest share of the global facial injectables market in 2018. In North America, the US and Canada are the leading countries with the newest advancements and comprehensive options in choosing aesthetic/cosmetic treatments. Europe is the second leading region. The market in Europe was largely driven by advancements in aesthetic techniques and growing cosmetic trends. An increase in the aging population, high adoption of advanced products, and increasing demand for minimally invasive procedures are driving the market. The leading European countries are Germany, France, UK, and Italy.
The APAC region is expected to grow faster due to the increased adoption of dermal fillers. The growing number of facial aesthetic clinics offer immense opportunities for the market growth. HA dermal filler treatments, in particular, are gaining popularity in the fast-growing network of spas and beauty clinics in APAC. India and China are estimated to be the fastest-growing countries in this region. Dermal fillers are likely to show strong potential as consumers are moving toward using non-invasive and low-cost anti-aging aesthetic treatments.

Competitive Analysis The competition among leading vendors is due to the availability of a wide range of facial injectables with different brand names in the market. This provides an opportunity for healthcare consumers to choose products based on brand, price, features, model, and discount. Most of the vendors are focusing on delivering bundling product models for increasing their sales and having a larger market share in terms of revenue. Many vendors have established their market presence globally and focus strongly on marketing and selling their products by competing with small and regional vendors. Therefore, the competition among the vendors is expected to hinder the market growth, yet the market will have more products developed and launched in the market. Most of the vendors are primarily focusing on R&D to offer fast technological progress. Manufacturers, including major and mid-sized companies, in the facial injectables market are competing with newer products, advanced features, quality, safety, and efficacy.
The competition is growing among the healthcare service providers hospitals, dermatology centers, and physicians offices where the customer groups are being consolidated for purchasing products. Diversified product portfolio companies, large volume product buyers (hospitals), and primary competitors (single product manufacturers) have strong market positions in certain segments and regions due to their wide range of products and services they offer. New competitors, especially from Asia, are also taking the competition to a new high with quality, safety, and efficacy of the product over the past few years.

Key Vendors:
Allergan plc
Galderma
Merz Pharma GmbH & Co. KGaA
Ipsen S.A.

Key Competitive Facts:
The market is highly competitive, with all the players competing to gain the market share. Intense competition, rapid advancements in technology, frequent changes in government policies, and prices are the key factors that confront the market.
The requirement of high initial investment, implementation, and maintenance cost in the market are also limiting the entry of new players.
Responding to competitive pricing pressures specific to each of our geographic markets.
Protection of proprietary technology for products and manufacturing processes.

Benefits The report provides complete details about the usage and adoption rate of facial injectables. Thus, the key stakeholders can know about the major trends, drivers, investments, vertical players initiatives, and government initiatives toward the medical devices segment in the upcoming years along with details of the pureplay companies entering the market. Moreover, the report provides details about the major challenges that are going to impact the market growth. Additionally, the report gives complete details about the key business opportunities to key stakeholders in order to expand their business and capture the revenue in specific verticals and to analyze before investing or expanding the business in this market.

Key Takeaways:
Understanding the potential market opportunity with precise market size and forecast data.
Detailed market analysis focusing on the growth of facial injectables in the aesthetic industry.
Factors influencing the growth of the facial injectables market.
In-depth competitive analysis of dominant and pureplay vendors.
Prediction analysis of the facial injectables industry in both developed and developing regions.
Key insights related to major segments of the facial injectables market.
The latest market trend analysis impacting the buying behavior of the consumers.



1Industry Outlook
1.1Medical Devices Industry
1.1.1Overview
1.1.2Facial Aesthetics
1.1.2.1Facial Aesthetics
1.1.2.2Botox
1.1.2.3Dermal Fillers
1.1.2.4Chemical Peel
1.1.2.5Microdermabrasion
1.1.3Materials Used in Soft Tissue Fillers
1.1.3.1Absorbable Materials
1.1.3.2Non-absorbable Materials
1.1.4Industry Trends
1.2Healthcare Spending
1.2.1US
1.2.2Europe
1.3Regulatory Bodies & Standards
1.4Emerging Global Markets
1.5Patient Demographics
1.6PESTLE Analysis
2Report Outline
2.1Report Scope
2.2Report Summary
2.3Research Methodology
2.4Report Assumptions
3Market Snapshot
3.1Total Addressable Market
3.2Segmented Addressable Market
3.3Opportunity Analysis
3.4Strategic Initiatives
3.5Related Markets
3.5.1Facial Aesthetics Market
3.5.2Dental Implants Market
3.5.3Breast Implant Market
3.5.4Energy-based Aesthetic Devices Market
3.6Porter 5 (Five) Forces
4Market Characteristics
4.1Evolution
4.2Market Dynamics
4.2.1Drivers
4.2.1.1Rise in focus on physical appearance to reverse the sign of aging
4.2.1.2Rising geriatric population
4.2.1.3Increased preference for minimally invasive cosmetic surgeries
4.2.1.4Increasing awareness about anti-aging skincare measures
4.2.1.5Increase in disposable income
4.2.2Restraints
4.2.2.1Complications and risks associated with facial injectables
4.2.2.2High cost of facial injectables
4.2.2.3Threat of counterfeit products in the market
4.2.2.4Paucity of skilled professionals
4.2.2.1Intense competition among vendors
4.2.3Opportunities
4.2.3.1Technological advancements
4.2.3.2Upsurge in medical tourism
4.2.3.3Increase in the demand for combination treatments
4.2.3.4Increase in healthcare spending
4.2.4DRO Impact Analysis
4.3Product Type Segmentation Market Size and Forecast
4.3.1Dermal Fillers
4.3.1.1Overview
4.3.2Featured Products
4.3.3Botox
4.3.3.1Overview
4.3.4Featured Products
4.4Key Stakeholders
5End-users
5.1Overview
5.2Hospitals
5.3Dermatology Centers
5.4Physicians Office
6Regions
6.1Overview
6.2North America
6.2.1Overview
6.2.2Market Developments
6.3Europe
6.3.1Overview
6.3.2Market Developments
6.4APAC
6.4.1Overview
6.4.2Market Developments
6.5Rest of the World
6.5.1Overview
6.5.2Market Developments
7Competitive Landscape
7.1Competitor Comparison Analysis
7.1.1Competitiveness
7.1.2Key Competitive Facts
8Vendors Profile
8.1Allergan plc
8.1.1Overview
8.1.2Business Units
8.1.3Business Focus
8.1.4SWOT Analysis
8.1.5Business Strategies
8.2Galderma
8.2.1Overview
8.2.2Business Focus
8.2.3SWOT Analysis
8.2.4Business Strategies
8.3Merz Pharma Gmbh & Co. KGaA
8.3.1Overview
8.3.2Geographic Presence
8.3.3Business Focus
8.3.4SWOT Analysis
8.3.5Business Strategies
8.4Ipsen S.A.
8.4.1Overview
8.4.2Business Units
8.4.3Geographic Presence
8.4.4Business Focus
8.4.5SWOT Analysis
8.4.6Business Strategies
9Companies to Watch For
9.1Sinclair Pharma Plc
9.1.1Overview
9.1.2Business Strategies
9.2Bloomage BioTechology Corp. Ltd.
9.2.1Overview
9.2.2Key Highlights
9.2.3Business Strategies
9.3Bausch Health Companies Inc. (formerly Valeant Pharmaceuticals International Inc)
9.3.1Overview
9.3.2Key Highlights
9.3.3Business Strategies
10Other Prominent Vendors
11Annexure

List Of Tables



TABLE 1MEDICAL DEVICES BY CATEGORY11
TABLE 2TOP LISTED MEDICAL DEVICES COMPANY IN 201812
TABLE 3FACIAL INJEC MARKET OUTLOOK31
TABLE 4AVERAGE COST OF DERMAL FACIAL FILLERS42
TABLE 5DRO OF DERMAL FILLERS MARKET51
TABLE 6DRO OF BOTOX MARKET53
TABLE 7GLOBAL FACIAL INJEC MARKET BY END-USERS57
TABLE 8GLOBAL FACIAL INJEC REVENUE BY REGIONS, 20192025 ($MILLION)61
TABLE 9DRO (NORTH AMERICA)62
TABLE 10DRO (EUROPE)64
TABLE 11DRO (APAC)65
TABLE 12DRO (REST OF THE WORLD)67
TABLE 13COMPETITIVE STRUCTURE ANALYSIS OF GLOBAL FACIAL INJEC MARKET (2018)71
TABLE 14ALLERGAN PLC: PRODUCT OFFERINGS72
TABLE 15ALLERGAN PLC: RECENT DEVELOPMENTS73
TABLE 16GALDERMA: PRODUCT OFFERINGS79
TABLE 17GALDERMA: RECENT DEVELOPMENTS80
TABLE 18MERZ PHARMA GMBH & CO. KGAA: PRODUCT OFFERINGS84
TABLE 19MERZ PHARMA GMBH & CO. KGAA: RECENT DEVELOPMENTS85
TABLE 20IPSEN S.A.: PRODUCT OFFERINGS89
TABLE 21IPSEN S.A.: RECENT DEVELOPMENTS89
TABLE 22SINCLAIR PHARMA PLC: SNAPSHOT95
TABLE 23SINCLAIR PHARMA PLC: RECENT DEVELOPMENTS96
TABLE 24BLOOMAGE BIOTECHNOLOGY CORPORATION LIMITED: SNAPSHOT98
TABLE 25BLOOMAGE BIOTECHNOLOGY CORPORATION LIMITED: RECENT DEVELOPMENTS98
TABLE 26VALEANT PHARMACEUTICALS INTERNATIONAL INC: SNAPSHOT100
TABLE 27VALEANT PHARMACEUTICALS INTERNATIONAL, INC.: RECENT DEVELOPMENTS100
TABLE 28OTHER PROMINENT VENDORS IN THE GLOBAL FACIAL INJEC MARKET104

?

Facial Injectables Market By Product Type (Dermal Fillers, Botox), By End-user (Hospitals, Dermatology Centers, Physicians Office), By Region (North America, Europe, Asia Pacific, RoW) – Global Forecast up to 2025

Global Facial Injectables Market by Product Types (Dermal Fillers, Botox), By End-users (Hospitals, Dermatology Centers, Physicians Office), and By Regions (North America, Europe, Asia Pacific, and Rest of the World)

USD 2750 View Report

North America Facial Injectable Market Report (2014-2024) - Market Size, Share, Price, Trend and Forecast

Abstract:The North America Facial Injectable market size is $XX million USD in 2018 with XX CAGR from 2014 to 2018, and it is expected to reach $XX million USD by

USD 3000 View Report

Global Facial Injectables Market Research Report 2019-2023

Facial Injectables can be used to plump up your skin and even your lips. In the context of China-US trade war and global economic volatility and uncertainty, it will have

USD 2850 View Report

Global Facial Injectables Market Report 2019, Competitive Landscape, Trends and Opportunities

The Facial Injectables market has witnessed growth from USD XX million to USD XX million from 2014 to 2019. With the CAGR of X.X%, this market is estimated to reach

USD 2950 View Report

Fill The Form For Sample Request

Note : * Kindly provide us with your company id and get the sample reports at the earliest.

There is no Reviews available